High‐sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma
Open Access
- 3 October 1999
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 107 (1), 121-131
- https://doi.org/10.1046/j.1365-2141.1999.01685.x
Abstract
Sensitive techniques for monitoring minimal residual disease (MRD) in multiple myeloma (MM) are needed to evaluate the effectiveness of new intensive treatment strategies. The aim of the present study was to explore the applicability and sensitivity of flow cytometry immunophenotyping and DNA ploidy studies for the investigation of residual myelomatous plasma cells (PC) in MM patients. Bone marrow (BM) samples from 61 untreated MM patients were immunophenotypically analysed with a panel of 21 monoclonal antibodies, using a high‐sensitive method based on a two‐step acquisition procedure through a SSC/CD38+++‐CD138+‘live‐gate’. Overall, in 87% of MM cases, PC displayed an aberrant phenotype at diagnosis. The most important aberrant criteria were: antigen over‐expression of CD56 (62%), CD28 (16%) and CD33 (6%) and asynchronous expression of CD117 (28%), sIg (21%) and CD20 (10%). DNA aneuploidy was found in 62% of cases. The simultaneous use of these two techniques allowed the detection of aberrant/aneuploid PC in 95% of the cases. Based on dilutional experiments, the detection limit of both techniques ranged from 10−4 to 10−5. In 29 stem cells harvests and 19 BM samples obtained 3 months after autologous transplantation, we have investigated the presence of residual myelomatous PC; they were detected in 44% of the stem cell collections and in 61% of the BM samples obtained after transplant. The percentage of pathological PC did not significantly change during the days of harvest. In summary, the present study shows that the combined use of immunophenotyping and DNA ploidy studies is a suitable approach for MRD investigation in MM patients based on their applicability (95% of cases) and sensitivity (up to 10−5).Keywords
This publication has 27 references indexed in Scilit:
- Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemiaThe Lancet, 1998
- Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish RegistryBone Marrow Transplantation, 1998
- A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumorsLeukemia, 1997
- Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonalBone Marrow Transplantation, 1997
- Detection of minimal residual disease in multiple myeloma and acute leukaemiaMedical Oncology, 1996
- DNA Cell Content Studies in Multiple MyelomaLeukemia & Lymphoma, 1996
- Hematopoietic Stem Cell Transplants for Multiple MyelomaLeukemia & Lymphoma, 1996
- Detection of minimal residual disease by polymerase chain reaction in b cell malignanciesThe International Journal of Cell Cloning, 1995
- Flow cytometry in the diagnosis of cancerScandinavian Journal of Clinical and Laboratory Investigation, 1995
- A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining techniqueCytometry, 1994